The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Improving response inhibition systems in frontotemporal dementia with citalopram
Open accessAbstract
Disinhibition is a cardinal feature of the behavioural variant of frontotemporal dementia, presenting as impulsive and impetuous behaviours that are often difficult to manage. The options for symptomatic treatments are limited, but a potential target for therapy is the restoration of serotonergic function, which is both deficient in behavioural variant frontotemporal dementia and closely associated with inhibitory control. Based on preclinical studies and psychopharmacological interventions in other disorders, we predicted that inhibition would be associated with the right inferior frontal gyrus and dependent on serotonin. Using magnetoencephalography and electroencephalography of a Go-NoGo paradigm, we investigated the neural basis of behavioural disinhibition in behavioural variant frontotemporal dementia and the effect of selective serotonin reuptake inhibition on the neural systems for response inhibition. In a randomized double-blinded placebo-controlled crossover design study, 12 patients received either a single 30 mg dose of citalopram or placebo. Twenty age-matched healthy controls underwent the same magnetoencephalography/electroencephalography protocol on one session without citalopram, providing normative data for this task. In the control group, successful NoGo trials evoked two established indices of successful response inhibition: the NoGo-N2 and NoGo-P3. Both of these components were significantly attenuated by behavioural variant frontotemporal dementia. Cortical sources associated with successful inhibition in control subjects were identified in the right inferior frontal gyrus and anterior temporal lobe, which have been strongly associated with behavioural inhibition in imaging and lesion studies. These sources were impaired by behavioural variant frontotemporal dementia. Critically, citalopram enhanced the NoGo-P3 signal in patients, relative to placebo treatment, and increased the evoked response in the right inferior frontal gyrus. Voxel-based morphometry confirmed significant atrophy of inferior frontal gyrus, alongside insular, orbitofrontal and temporal cortex in our patient cohort. Together, these data suggest that the dysfunctional prefrontal cortical systems underlying response inhibition deficits in behavioural variant frontotemporal dementia can be partially restored by increasing serotonergic neurotransmission. The results support a translational neuroscience approach to impulsive neurological disorders and indicate the potential for symptomatic treatment of behavioural variant frontotemporal dementia including serotonergic strategies to improve disinhibition.media-1vid110.1093/brain/awv133_video_abstractawv133_video_abstract.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Laura et al. found that citalopram can partially restore the dysfunctional prefrontal cortical systems by increasing serotonergic neurotransmission in FTD.
“In line with our observation, Laura et al. [56] found that citalopram can partially restore the dysfunctional prefrontal cortical systems by increasing serotonergic neurotransmission in FTD.”
From Antidepressant use and cognitive decline in patients with dementia: a national cohort study (2025) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J. R. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1610 · Cited by 2,016
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771
Self-citationNieuwenhuis, S., Yeung, N., van den Wildenberg, W., & Ridderinkhof, K. R. (2003) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/cabn.3.1.17 · Cited by 1,250
Executive “Brake Failure” following Deactivation of Human Frontal Lobe
Chambers, C. D., Bellgrove, M. A., Stokes, M. G., Henderson, T. R., Garavan, H., Robertson, I. H., Morris, A. P., & Mattingley, J. B. (2006) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2006.18.3.444 · Cited by 544
Frontal Paralimbic Network Atrophy in Very Mild Behavioral Variant Frontotemporal Dementia
Seeley, W. W., Crawford, R., Rascovsky, K., Kramer, J. H., Weiner, M., Miller, B. L., & Gorno-Tempini, M. L. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.38 · Cited by 506
Enriquez-Geppert, S., Konrad, C., Pantev, C., & Huster, R. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.043 · Cited by 376
Bari, A., Theobald, D. E., Caprioli, D., Mar, A. C., Aidoo-Micah, A., Dalley, J. W., & Robbins, T. W. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.233 · Cited by 325
Self-citationA systematic review of neurotransmitter deficits and treatments in frontotemporal dementia
Huey, E. D., Putnam, K. T., & Grafman, J. (2006) · Neurology · doi:10.1212/01.wnl.0000191304.55196.4d · Cited by 299
Del-Ben, C. M., Deakin, J. F. W., Mckie, S., Delvai, N. A., Williams, S. R., Elliott, R., Dolan, M., & Anderson, I. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300728 · Cited by 260
Rubia, K., Lee, F., Cleare, A. J., Tunstall, N., Fu, C. H. Y., Brammer, M., & McGuire, P. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2116-z · Cited by 171
Klein, N., Sacher, J., Geiss-Granadia, T., Attarbaschi, T., Mossaheb, N., Lanzenberger, R., Pötzi, C., Holik, A., Spindelegger, C., Asenbaum, S., et al. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0486-0 · Cited by 77
Measuring disease progression in frontotemporal lobar degeneration: A clinical and MRI study
Gordon, E., Rohrer, J. D., Kim, L. G., Omar, R., Rossor, M. N., Fox, N. C., & Warren, J. D. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d1a879 · Cited by 70
Response inhibition in adults and teenagers: Spatiotemporal differences in the prefrontal cortex
Vidal, J., Mills, T., Pang, E. W., & Taylor, M. J. (2012) · Brain and Cognition · doi:10.1016/j.bandc.2011.12.011 · Cited by 61 · cited 2×
“Inferior frontal and temporal activity has been identified using MEG in association with NoGo inhibition in healthy adults (Vidal et al., 2012) and adolescents (Vara et al., 2014).”
BackgroundMethodReorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy
Hughes, L. E., Ghosh, B. C. P., & Rowe, J. B. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.03.009 · Cited by 60
Self-citation
Flagged first, then by citations
Research works printed but not linked: 94
- 10.1016/j.neuroimage.2013.03.011 · DOI
- Almeida, 2010, Acute citalopram administration may disrupt contextual information processing in healthy males, Eur Psychiatry, 25, 87, 10.1016/j.eurpsy.2009.05.010 · DOI
- 10.1097/00001756-200208270-00012 · DOI · Paper page
- 10.1016/j.tics.2004.02.010 · DOI · Paper page
- 10.1016/j.tics.2013.12.003 · DOI · Paper page
- 10.1016/j.neuroimage.2007.07.007 · DOI · Paper page
- 10.1016/S0001-6918(99)00005-0 · DOI · Paper page
- Bentivoglio, 2012, Neuropsychological features of patients with Parkinson's disease and impulse control disorders, Neurol Sci, 34, 1207, 10.1007/s10072-012-1224-5 · DOI
- 10.1016/0013-4694(94)90094-9 · DOI · Paper page
- 10.1016/j.neuropsychologia.2011.05.014 · DOI
- 10.1016/j.neuropsychologia.2007.12.008 · DOI
- 10.1016/j.neuropsychologia.2004.08.010 · DOI
- 10.1016/j.bbr.2012.08.003 · DOI
- 10.1007/s00213-007-0992-8 · DOI
- 10.1097/WAD.0b013e31815c345e · DOI
- 10.1016/j.biopsych.2004.02.029 · DOI · Paper page
- 10.1007/s00213-001-0986-x · DOI
- 10.1016/S0010-9452(08)70686-5 · DOI
- 10.1016/j.biopsych.2011.03.028 · DOI · Paper page
- 10.1038/npp.2010.121 · DOI · Paper page
- 10.1016/j.tics.2007.10.011 · DOI · Paper page
- 10.1016/j.jneumeth.2008.12.010 · DOI
- 10.1007/s00213-003-1686-5 · DOI
- 10.1016/j.bandc.2004.04.005 · DOI · Paper page
- 10.1212/WNL.55.11.1621 · DOI · Paper page
- 10.1007/s00213-008-1127-6 · DOI · Paper page
- 10.1038/npp.2008.202 · DOI
- 10.1007/s00213-006-0411-6 · DOI · Paper page
- 10.1016/j.clinph.2006.05.002 · DOI
- 10.1027//0269-8803.16.3.167 · DOI · Paper page
- 10.1016/j.cortex.2012.09.008 · DOI
- 10.1002/ana.20365 · DOI
- 10.1017/S0317167100005680 · DOI
- 10.1111/j.1469-8986.1991.tb00417.x · DOI
- 10.1098/rstb.2012.0407 · DOI
- 10.1016/S0166-4328(98)00117-X · DOI
- 10.1097/JGP.0b013e31823033f3 · DOI
- 10.1093/brain/awr196 · DOI
- 10.1162/jocn_a_00356 · DOI
- 10.1016/j.ijpsycho.2012.08.001 · DOI
- 10.1016/j.neuroimage.2014.02.034 · DOI
- 10.1159/000076343 · DOI
- Ishikawa, 2006, Stereotyped behaviors and compulsive complaints of pain improved by fluvoxamine in two cases of frontotemporal dementia, Seishin Shinkeigaku Zasshi, 108, 1029
- 10.1002/mds.26049 · DOI
- 10.1016/j.euroneuro.2013.01.003 · DOI
- 10.1093/brain/awp077 · DOI
- 10.1097/WCO.0b013e3283404309 · DOI
- 10.1093/brain/122.5.981 · DOI · Paper page
- 10.1046/j.1460-9568.1998.00167.x · DOI · Paper page
- 10.1186/1471-2377-13-179 · DOI
- 10.1016/j.pscychresns.2007.07.003 · DOI
- 10.1159/000077171 · DOI
- 10.1038/npp.2012.264 · DOI
- 10.1016/j.neuroimage.2003.09.032 · DOI
- 10.1016/S1053-8119(03)00169-1 · DOI
- 10.1002/mds.20465 · DOI
- 10.1159/000067021 · DOI
- 10.1371/journal.pone.0085747 · DOI
- 10.1196/annals.1377.004 · DOI
- 10.1097/WAD.0b013e318265bbc9 · DOI
- 10.1016/j.cortex.2012.12.003 · DOI
- Pascual-Marqui, 2002, Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details, Methods Find Exp Clin Pharmacol, 24, 5
- 10.1212/WNL.0b013e3181a55fa2 · DOI
- 10.1016/j.nbd.2010.05.028 · DOI
- 10.1126/scitranslmed.3003391 · DOI
- 10.1016/j.neurobiolaging.2014.07.008 · DOI
- 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J · DOI
- 10.1159/000051219 · DOI
- 10.1016/j.clinph.2011.05.012 · DOI
- 10.1093/brain/awr179 · DOI · Paper page
- 10.1098/rstb.2007.2097 · DOI · Paper page
- 10.1007/s00221-004-1985-z · DOI
- 10.1212/WNL.0b013e318202038c · DOI · Paper page
- 10.1093/brain/awn112 · DOI
- 10.1006/nimg.2000.0685 · DOI · Paper page
- 10.1007/s00702-008-0042-7 · DOI
- Sangkuhl, 2011, PharmGKB summary: citalopram pharmacokinetics pathway, Pharmacogenet Genomics, 769, 10.1097/FPC.0b013e328346063f · DOI
- 10.1001/archneur.61.7.1104 · DOI
- 10.1016/j.ijpsycho.2012.07.185 · DOI
- 10.1016/j.clinph.2007.11.042 · DOI
- 10.1016/j.ijpsycho.2009.11.002 · DOI
- 10.1001/archneur.1991.00530200032014 · DOI
- 10.4088/JCP.v58n0506 · DOI
- 10.1016/j.neuroimage.2011.02.070 · DOI · Paper page
- 10.1006/nimg.2001.0978 · DOI · Paper page
- Vara, 2014, Is inhibitory control a ‘no-go' in adolescents with autism spectrum disorder?, Molecular Autism, 31, 6, 10.1186/2040-2392-5-6 · DOI
- 10.1111/j.1460-9568.2005.04571.x · DOI · Paper page
- 10.1136/jnnp.2007.122028 · DOI
- 10.1001/archneurol.2010.65 · DOI
- 10.1212/01.wnl.0000343851.46573.67 · DOI
- 10.1016/j.neuroimage.2004.10.023 · DOI
- Yang, 2001, Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method, Acta Neuropathol, 101, 256, 10.1007/s004010000293 · DOI
- Ye, 2014, Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease, Brain, 197, 145
- 10.1162/jocn.2008.20100 · DOI
Cited by
Sorted by citations
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122
Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia
Hughes, L. E., Rittman, T., Robbins, T. W., & Rowe, J. B. (2018) · Brain · doi:10.1093/brain/awy176 · Cited by 81
Self-citationAdvances in treatment of frontotemporal dementia
Magrath Guimet, N., Zapata-Restrepo, L. M., & Miller, B. L. (2022) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.21060166 · Cited by 52
Antidepressant use and cognitive decline in patients with dementia: a national cohort study
Mo, M., Abzhandadze, T., Hoang, M. T., Sacuiu, S., Jurado, P. G., Pereira, J. B., Naia, L., Kele, J., Maioli, S., Xu, H., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-03851-3 · Cited by 45
Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia
Le, C., & Finger, E. (2021) · CNS Drugs · doi:10.1007/s40263-021-00854-5 · Cited by 26
Metabolomic changes associated with frontotemporal lobar degeneration syndromes
Murley, A. G., Jones, P. S., Coyle Gilchrist, I., Bowns, L., Wiggins, J., Tsvetanov, K. A., & Rowe, J. B. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09824-1 · Cited by 18
Self-citation
Metadata
- Authors
- Hughes, L. E., Rittman, T., Regenthal, R., Robbins, T. W., & Rowe, J. B.
- Affiliations
- MRC Cognition and Brain Sciences Unit (GB)
- University of Cambridge (GB)
- Leipzig University (DE)
- Corresponding author
- Hughes, Laura E.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-05-21
- Volume
- 138
- Issue
- 7
- Pages
- 1961-1975
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5412666
- OpenAlex
- W1908432422
- Cited by
- 100
- References
- 14
- Citations by year
- 2026: 14 · 2025: 9 · 2024: 7 · 2023: 5 · 2022: 11 · 2021: 17 · 2020: 9 · 2019: 5 · 2018: 5 · 2017: 7 · 2016: 10 · 2015: 1
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Brain (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (103838/Z/14/Z, 103838, 088324, 093875)
- Medical Research Council (MR/M024873/1, MR/M009041/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Social Sciences › Psychology › Clinical Psychology › Historical and Modern Theater Studies
- Keywords
- behavioral variant frontotemporal dementia, citalopram, response inhibition, disinhibition, serotonergic function, selective serotonin reuptake inhibitors, go/no-go task, Nogo-P3, Nogo-N2, right inferior frontal gyrus, anterior temporal lobe, prefrontal cortex, cortical atrophy, impulsivity, symptomatic treatment
- MeSH terms
- Aged, Double-Blind Method, Electroencephalography, Female, Humans, Inhibition, Psychological, Magnetic Resonance Imaging, Male, Middle Aged, Magnetoencephalography, Citalopram, Selective Serotonin Reuptake Inhibitors, Cross-Over Studies, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review